Recall rate (RR) is considered one of the key performance indicators of any breast screening programme[1]. This is the proportion of women undergoing screening mammography who are requested to return for further imaging. Recall is necessary to further evaluate lesions suspicious for breast cancer. However, there is a fine balance in maintaining high cancer detection rates (CDR) while minimising false positive recalls, where women are recalled for benign findings. Having a false positive recall c…